Moderna Inc. said Thursday that preliminary clinical trial data show that its updated COVID-19 vaccine is effective against newer variants that are starting...
Moderna Inc. said Thursday that preliminary clinical trial data show that its updated COVID-19 vaccine is effective against newer variants that are starting to circulate widely. The shot significantly boosted neutralizing antibodies against the Eris, or EG.5, variant, as well as the Fornax FL 1.5.1 variant that is starting to surge in parts of the U.S., the company said in a release.
shares gained 3.4%, and Pfizer Inc. PFE, +2.90% stock rose 2.9%.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Covid vaccines are on the way as 'Eris' variant risesA new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from 'Er...
Read more »
What to Know About New COVID Vaccines as ‘Eris’ Variant DominatesFind out if you’ll need another shot.
Read more »
These are the fastest growing companies in Greater Cleveland, according to the Inc. 5000Cleveland Kitchen, Fund That Flip and The Connect Group are the fastest growing companies in Greater Cleveland.
Read more »
Craft spirits distributor tops Dallas-Fort Worth’s entrants on Inc. 5000 for 2023Topping the Inc. 5000 list for North Texas-based companies is Coppell’s Green Light Distribution, which boasts that it wants to “even the playing field” for...
Read more »
As the new Eris Covid variant spreads across the world, here’s what we know so farEG.5 or 'Eris,' now the dominant variant in the United States, is currently thought to have the same risk level as existing variants.
Read more »
Top 3 Tech Stocks Poised to Surge Amid Growing Likelihood of Soft Landing ScenarioStocks Analysis by Investing.com (Damian Nowiszewski) covering: STMicroelectronics NV ADR, Belden Inc, Vishay Intertechnology Inc. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Read more »